Precision BioSciences Inc... (DTIL)
4.71
0.01 (0.21%)
At close: Mar 31, 2025, 3:59 PM
4.75
0.86%
After-hours: Mar 31, 2025, 07:16 PM EDT
Precision BioSciences Balance Sheet Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Cash & Equivalents | 85.9M | 116.68M | 189.58M | 143.66M | 89.8M | 180.89M | 103.19M | 62.8M | 93.42M |
Short-Term Investments | 413K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 3.21M | 8.2M | 4.75M | 6.84M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 27.39M | 225K | 9.8M | 4.64M | 1.72M | 558K | 312K | 124K | 468K |
Receivables | 1.7M | 12.8M | 720K | 488K | 10M | 965K | 523K | 22K | 386K |
Inventory | n/a | n/a | 7.55M | 17.43M | 5.76M | 9.5M | n/a | n/a | n/a |
Other Current Assets | 8.45M | 6.88M | 8.81M | 17.6M | 5.77M | 11.82M | 11.96M | 1.51M | 593K |
Total Current Assets | 94.99M | 136.36M | 199.1M | 161.75M | 105.56M | 193.67M | 115.67M | 64.33M | 94.4M |
Property-Plant & Equipment | 10.18M | 14.6M | 23.16M | 29.33M | 41.5M | 39.57M | 21.15M | 8.14M | 3.54M |
Goodwill & Intangibles | 622K | 400K | 1.35M | 2.05M | 1.37M | 1.43M | 1.47M | 90K | n/a |
Total Long-Term Assets | 41.4M | 23.42M | 39.06M | 49.74M | 44.59M | 41.56M | 22.93M | 8.35M | 4.01M |
Total Assets | 136.39M | 159.78M | 238.17M | 211.5M | 150.16M | 235.23M | 138.6M | 72.68M | 98.41M |
Account Payables | 1.31M | 2.97M | 653K | 1.14M | 792K | 2.04M | 2.22M | 1.81M | 1.29M |
Deferred Revenue | 2.96M | 12.04M | 46.19M | 21.24M | 30.24M | 16.49M | 8.44M | 5.82M | 6.21M |
Short-Term Debt | 2.64M | 23.55M | 1.68M | 3.64M | 3.87M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 8.07M | 11.44M | 11.14M | 9.95M | 7.93M | 8.41M | 3.42M | 1.57M | 845K |
Total Current Liabilities | 14.98M | 49.99M | 59.66M | 35.98M | 42.83M | 26.93M | 14.07M | 9.2M | 8.34M |
Long-Term Debt | n/a | 7.72M | 23.28M | 7.29M | 8.59M | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 65.02M | 128K | 1.92M | 44K | 392K | 4.09M | 1.76M | 1.25M | 433K |
Total Long-Term Liabilities | 65.02M | 90.93M | 118.07M | 84.35M | 62.9M | 69.99M | 84.56M | 89.85M | 94.82M |
Total Liabilities | 80M | 140.92M | 177.74M | 120.33M | 105.73M | 96.92M | 98.64M | 99.05M | 103.16M |
Total Debt | 1.32M | 31.27M | 27.04M | 9.11M | 10.52M | n/a | n/a | n/a | n/a |
Common Stock | 1K | 1K | 1K | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -482.46M | -489.63M | -428.31M | -316.68M | -286.07M | -177.07M | -85.19M | -39.11M | -18.01M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | -5.48M | -3.19M | n/a |
Shareholders Equity | 56.39M | 18.86M | 60.43M | 91.17M | 44.42M | 138.31M | 39.96M | -26.37M | -4.75M |
Total Investments | 3.62M | 8.2M | 4.75M | 6.84M | n/a | n/a | n/a | n/a | n/a |